Blood PGC-1α Concentration Predicts Myocardial Salvage and Ventricular Remodeling After ST-segment Elevation Acute

Óscar Fabregat-Andrés1, Francisco Ridocci-Soriano2, Jordi Estornell-Erill3

  • 1Servicio de Cardiología, Consorcio Hospital General Universitario de Valencia, Valencia, Spain; Fundación de Investigación, Hospital General de Valencia, Valencia, Spain.

Insights

Detecting Peroxisome proliferator-activated receptor gamma coactivator 1α (PGC-1α) in blood after myocardial infarction predicts better heart recovery. Higher PGC-1α levels indicate greater myocardial salvage and less ventricular remodeling post-infarction.

Area of Science:

  • Cardiology
  • Biochemistry
  • Molecular Biology

Background:

  • Peroxisome proliferator-activated receptor gamma coactivator 1α (PGC-1α) is a key metabolic regulator.
  • PGC-1α is induced during ischemia and has shown cardioprotective effects in animal models.
  • Assessing PGC-1α activity in ST-segment elevation acute myocardial infarction (STEMI) patients is feasible.

Purpose of the Study:

  • To evaluate the predictive value of blood PGC-1α levels for myocardial necrosis extent.
  • To assess the association of PGC-1α levels with ventricular remodeling after infarction.
  • To determine the relationship between PGC-1α expression and myocardial salvage in STEMI patients.

Main Methods:

  • Prospective study of 31 first-time anterior STEMI patients with successful reperfusion.
  • PGC-1α expression measured in peripheral blood on admission and at 72 hours.
  • Cardiac magnetic resonance imaging (MRI) used to assess edema, necrosis, infarct size, and ventricular remodeling at 6 months.

Main Results:

  • Patients with detectable baseline PGC-1α showed significantly greater myocardial salvage (18.3% vs 4.5%, P=.04).
  • Induction of PGC-1α at 72 hours correlated with increased ventricular remodeling (29.7% vs 1.2% change in LVEDV, P=.04).

Conclusions:

  • Baseline PGC-1α expression is linked to greater myocardial salvage after acute myocardial infarction.
  • An attenuated systemic PGC-1α response predicts less ventricular remodeling.
  • Blood PGC-1α levels may serve as a biomarker for predicting outcomes post-STEMI.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
484
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
789
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.9K